Percutaneous intervention for the treatment of various cardiac disorders, including coronary artery disease (CAD), peripheral artery disease (PAD), became a well verified technique and has also been recently extended for treating neurovascular disorders such as carotid artery disease. However, distal embolization of various particulate matters such as plaque debris, including fibrin, necrotic atheromatous core, foam cells, cholesterol clefts, and thrombus, at the time of balloon inflation or stent deployment, complicate percutaneous interventions than before. Currently, the risk of distal embolization is considered significant in carotid arteries, degenerated SVG, and thrombotic lesions characterizing the patient affected by acute coronary syndromes. The process of plaque embolization requires a complex interaction that also involves microvascular spasm and thrombosis. Most often, this results in diminished blood flow to the distal vascular bed, potentially complicated by periprocedural ischemia and/or infarction or stroke. In particular, the risk of distal embolization is mainly high in degenerated SVGs, with no reflow being reported in up to 31.8% of cases during the treatment of thrombotic lesions and in up to 7.9% of cases with no thrombus present. However, large particles more than 100 μm may obstruct large, epicardial vessels; very small particles, with 15–50 μm, can also obstruct the microvascular bed causing microinfarcts and left ventricular dysfunction.

The artificially produced UV-C radiation has been in use for many decades and successfully being used as a germicide or bactericide. The demand for UV-C based systems and equipment has grown steadily in the last century. However, post-2000, the traction for such systems increased as many applications in the commercial and industrial sectors gained popularity on a larger scale. The increase in the number of viral infections and epidemics such as SARS, Dengue, Ebola, Chikungunya, Zika, and Nipah also aided in the development of germicidal lamps that would reduce the infectious disease spread by way of sterilization. The UV-C based systems and equipment act as an alternative to chemical-based disinfection mechanism in many end-use sectors, especially in water treatment, where generally chlorine is used for destroying microorganisms. Ultraviolet germicidal irradiation (UVGI) in the UV-C band is used for water, air, and surface disinfection. UV-C energy is used to interrupt the transmission of pathogenic organisms such as Mycobacterium tuberculosis (TB), influenza viruses, molds, and possible bioterrorism agents.

Historically, the evolution of inhalation therapy can be traced to India 4,000 years ago. The antecedents of contemporary inhalation therapy, however, began in the nineteenth-century industrial age with the invention of glass bulb nebulizers. Thereafter, inhaler technology evolved along two pathways, characterized by refinements in existent nebulizer technology and the invention of a portable inhalation device, the metered-dose inhaler (MDI) in the 1950s. This was the first device to effectively deliver medicine to the lungs. MDIs set the stage for asthma technology to be introduced, including breath-actuated MDIs, spacer devices, and dosage counters. Similarly, the 1970s also saw the development of breath-actuated MDIs for people who have difficulty synchronizing the working motion. This technology helps to breathe normally to activate and release the medication.

The global medical central vacuum systems market is expected to witness a rise in the use of non-conventional cleaning equipment such as centralized vacuum systems. Centralized vacuum systems are becoming ideal for residential and nonresidential segments where the systems are installed at a designated area, and their penetration is expected to be significant in the healthcare segment. The penetration of centralized vacuum systems in healthcare segments is driven by their use as a part of the design and operation mandate.

Medical device cleaning is a vital and integral part of any medical procedure. Medical devices are required to be cleaned and sterilized before being utilized in any medical procedures for the prevention of any kind of infection and cross-contamination among patients and healthcare workers. The factors that drive the growth of the global medical device cleaning market include the increasing prevalence of various chronic diseases and increasing investment for the development and re-use of the medical devices. Rising occurrence of acute diseases, as well as the growing demand for surgical procedures, are escalating the use of medical devices and the need to reprocess them. Apart from this, the rising investments by governments in improving healthcare infrastructure, coupled with increasing expenditure on healthcare by patients, are poised to work in favor of the market.

Mechanical and electromechanical locks have an established market worldwide, and their demand is also driven by the adoption of new doors in all buildings. Locks and access control systems have always been a standard component in both residential and non-residential buildings, including commercial and industrial buildings, and locks now have a long-established market. Most standard doors comprise of glass panes mounted in wooden or metal frames. Currently, the focus is on wood, plastic, and glass for internal doors and hardwood, metal, and fiberglass for external and exit doors. Residential buildings have at least one door and more than one window in every room. However, commercial buildings have a large number of doors, which enhances the demand for new locks with more new door orders across the globe.

An understanding of the global economic scenario is vital to make informed decisions regarding the fasteners market’s landscape. Emerging and developed economies might react to similar challenges in similar ways, but the implications and protective measures as well as their degree are different for different economies. In 2019, the global economic growth for 2020 was expected to be characterized by moderate recovery (1−3%) in the developed economies of Germany, the US, and the UK, average growth to outperformance (5−9%) in developing economies such as China and India, and contraction to flat growth in economies of Brazil, Russia, and the EU (1.20−1.50%). However, the spread of the coronavirus pandemic sent global economies into phases of lockdown, and almost all industries took a hit on their production, manufacturing, and operational capacities, even as essential services were carried out by skeleton staffing. As a result of COVID-19 and its impact on economies, the global economy is expected to contract by over 3% in 2020.

Spinal implants and devices are used to treat disorders and impairments related to spine. The scope of the report includes revenue generated from sales of spinal implant and devices, which are used during surgery for various spine disorders by practitioners. Recent advancements and developments in spinal implants and devices have enhanced their efficiency. Drivers, restraints, and opportunities are explained in detail to understand the market dynamics. Market share analysis and key strategies adopted by potential market leaders to facilitate effective planning and decision-making are also discussed in the report.

Surgical robotic systems market is segmented based on component, surgery type and region. The report considers only surgical robots which replace human hands/limbs during the time of surgery. The study includes only commercialized surgical robotic systems sold to hospitals and surgical centers. Based on component, the market is segmented into surgical system, surgical accessories and services. The study covers revenue generated from sales of surgical systems, accessories and services. The report excludes other nonrobotic or automated assistive devices, which are used during surgeries.

A mechanical ventilator is a machine, designed for moving breathable air into and out of lungs for a patient who is physically unable to breathe. It is operated under different mode of ventilation, which includes positive pressure ventilators under both non-invasive and invasive sub segments, whereas negative pressure ventilators (NPV) are excluded from the scope of study. The reason for exclusion of NPV is attributed to the technology as well as devices being obsolete in the current scenario. The market size and share of the aforementioned segments has been analyzed and mentioned in detail in the report. The report also provides an overview of the regions covered in the report. However, it excludes the revenue generated by services provided by healthcare services providers or hospitals. In this report the service component includes only product training, online and offline support, and maintenance related services.